A small observational study of ambulatory patients with COVID-19 found that 1.8% of untreated patients tested positive again after testing negative, compared to 20.8% of those who took five days of nirmatrelvir-ritonavir.
14 Nov 2023
A sizable number of patients with diabetes do not consistently fill their prescriptions or take less than the prescribed amount due to costs, but there are ways to make it easier on a patient's pocketbook.
1 May 2022
Even as Medicare seeks to negotiate down the costs of 10 prescription drugs, researchers are examining the effectiveness of existing private programs to provide lower drug costs and copays.
5 Sep 2023
At ACP's Global Forum in San Diego, attendees discussed how pharmaceutical pricing constitutes an overall health threat to patients.
1 Nov 2023
Transparency in pricing, cost, and comparative value and elimination of restrictions on using quality-adjusted life-years in comparative effectiveness research are 2 of the recommendations.
29 Mar 2016
ACP has 4 concrete proposals to address rising prescription drug prices: regulating and negotiating prices, enhancing transparency, increasing competition, and considering value.
1 May 2016
One study evaluated the effect of real-time pop-up recommendations for lower-priced prescription alternatives, while a second study modeled capping monthly expenses and shifting the patients' savings back to the insurance plan.
20 Sep 2022
This issue includes stories on long-acting reversible contraceptives, medications for type 2 diabetes, and issues affecting the elderly.
1 May 2022
The new policy paper is the third installment of a series. Previous papers have offered recommendations related to public health programs and pharmacy benefit managers.
15 Sep 2020
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
1 Jan 2020